Stage I non-seminomatous germ-cell tumours of the testis - identification of a subgroup of patients with a very low risk of relapse

By Alexandre J.   Fizazi K.   Mahe C.   Culine S.   Droz J.-P.   Theodore C.   Terrier-Lacombe M.-J.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 576-582

Elsevier

Access to resources Recommend Favorite

Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors

By Kawaguchi Tomohiro  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 779-787

Springer Publishing Company

Access to resources Recommend Favorite

Persisting Elevation of Alpha-fetoprotein After Chemotherapy for Germ Cell Tumour--Not Always Due to Viable Malignancy?

By Shannon J.A.   Donnellan M.J.   Friedlander M.L.   Harnett P.R.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1722-1722

Elsevier

Access to resources Recommend Favorite

Microsatellite Instability in Germ Cell Tumors of the Testis and Ovary

By Faulkner S.W.   Friedlander M.L.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 38-43

Elsevier

Access to resources Recommend Favorite

Programmed Cell Death in Response to Chemotherapeutic Agents in Human Germ Cell Tumour Lines

By Huddart R.A.   Titley J.   Robertson D.   Williams G.T.   Horwich A.   Cooper C.S.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 739-746

Elsevier

Access to resources Recommend Favorite